Scarica l'app Stockscreener
1.09
1.80%
-0.02
Dopo l'orario di chiusura:
1.10
0.01
+0.92%
Precedente Chiudi:
$1.11
Aprire:
$1.12
Volume 24 ore:
391.35K
Relative Volume:
1.73
Capitalizzazione di mercato:
$49.08M
Reddito:
-
Utile/perdita netta:
$-87.23M
Rapporto P/E:
-0.367
EPS:
-2.97
Flusso di cassa netto:
$-82.77M
1 W Prestazione:
-21.58%
1M Prestazione:
-25.34%
6M Prestazione:
-71.24%
1 anno Prestazione:
-93.91%
Intervallo 1D:
$1.05
$1.12
Intervallo di 1 settimana:
$1.05
$1.42
Portata 52W:
$0.8801
$19.30
Pepgen Inc Stock (PEPG) Company Profile
Nome
Pepgen Inc
Settore
Industria
Telefono
703-456-8000
Indirizzo
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Confronta PEPG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.09 | 49.08M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-21 | Iniziato | H.C. Wainwright | Buy |
Pepgen Inc Borsa (PEPG) Ultime notizie
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors - GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors to Secure Counsel Before Important - Bluefield Daily Telegraph
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG - GlobeNewswire Inc.
PepGen Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
PepGen Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm - Bluefield Daily Telegraph
PepGen Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before August 8, 2025 to Discuss Your Rights – PEPG - TradingView
Investors who lost money with shares of PepGen Inc. (NASDAQ: - openPR.com
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain OfficersPEPG - PR Newswire
PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PepGen Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Securities Lawsuit Alert: PepGen Inc. (PEPG)Contact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Join Class Action to Recover Losses from PepGen Inc. (PEPG)Contact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. Investors of a Class Action ... - Eagle-Tribune
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. - GlobeNewswire
Investors Urged to Contact Levi & Korsinsky for Information Before August 8, 2025PepGen Inc. (PEPG) - ACCESS Newswire
PEPGEN INC. (NASDAQ: PEPG) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein - GlobeNewswire
PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Notifies PepGen Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePEPG - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - PR Newswire
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before ... - Eagle-Tribune
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. - GlobeNewswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds PepGen Inc. (PEPG) Investors of August 8, 2025 Deadline - ACCESS Newswire
PepGen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your RightsPEPG - Kilgore News Herald
August 8, 2025 Deadline: Join Class Action Lawsuit Against PepGen Inc. (PEPG)Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Urges PepGen Inc. (PEPG) Shareholders to Act Before Lead Plaintiff Deadline August 8, 2025 - ACCESS Newswire
Levi & Korsinsky Reminds PepGen Inc. Investors of the - GlobeNewswire
PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit With Faruqi & Faruqi, LLP - Business Wire
Lost Money on PepGen Inc. (PEPG)? Join Class Action Before August 8, 2025Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: PepGen Inc. (PEPG) InvestorsContact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc. - The Malaysian Reserve
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PepGen Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit – PEPG - TradingView
Shareholders of PepGen Inc. Should Contact The Gross Law Firm Before August 8, 2025 to Discuss Your RightsPEPG - The Malaysian Reserve
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been ... - Bluefield Daily Telegraph
PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Levi & Korsinsky Notifies PepGen Inc. (PEPG) InvestorsLead Plaintiff Deadline on August 8, 2025 - ACCESS Newswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen - GlobeNewswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG - TradingView
PepGen Inc. (PEPG) LawsuitInvestors Urged to Contact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
PepGen Faces Investor Suit Over Muscular Dystrophy Drug - Law360
Investors in PepGen Inc. (PEPG): Protect Your RightsContact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
Levi & Korsinsky Notifies PepGen Inc. (PEPG) Shareholders of Class Action Lawsuit And August 8, 2025 Deadline - ACCESS Newswire
Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025PEPG - StreetInsider
Class Action Filed Against PepGen Inc. (PEPG) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionPEPG - ACCESS Newswire
PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit - The Malaysian Reserve
Pepgen Inc Azioni (PEPG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pepgen Inc Azioni (PEPG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McArthur James G | President and CEO |
Apr 17 '25 |
Buy |
1.35 |
10,000 |
13,550 |
113,913 |
| McArthur James G | President and CEO |
Apr 08 '25 |
Buy |
1.15 |
41,500 |
47,725 |
103,913 |
| DeLena Mary Beth | General Counsel |
Feb 26 '25 |
Sale |
1.68 |
1,432 |
2,406 |
1,568 |
| Donnelly Noel | Chief Financial Officer |
Feb 26 '25 |
Sale |
1.68 |
1,527 |
2,565 |
1,673 |
| Mellion Michelle L | Chief Medical Officer |
Jul 25 '24 |
Option Exercise |
10.21 |
7,571 |
77,300 |
7,571 |
| Mellion Michelle L | Chief Medical Officer |
Jul 24 '24 |
Option Exercise |
10.21 |
201 |
2,052 |
201 |
| Mellion Michelle L | Chief Medical Officer |
Jul 25 '24 |
Sale |
18.06 |
7,571 |
136,741 |
0 |
| Mellion Michelle L | Chief Medical Officer |
Jul 24 '24 |
Sale |
18.01 |
201 |
3,619 |
0 |
| Mellion Michelle L | Chief Medical Officer |
Jul 18 '24 |
Option Exercise |
10.21 |
12,625 |
128,901 |
12,625 |
| Mellion Michelle L | Chief Medical Officer |
Jul 18 '24 |
Sale |
18.20 |
12,625 |
229,804 |
0 |
0.39%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):